AI Integration And Leadership Changes Will Strengthen Healthcare Supply Chain Resilience

Published
11 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$22.33
11.7% overvalued intrinsic discount
14 Aug
US$24.95
Loading
1Y
23.9%
7D
6.9%

Author's Valuation

US$22.3

11.7% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on30 Apr 25
Fair value Increased 4.46%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 4.27%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 14%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 11%

AnalystConsensusTarget has increased profit margin from 7.4% to 9.9% and decreased future PE multiple from 22.8x to 17.3x.